Dr. Kevin Saunders discusses new vaccine that could prevent future pandemics

A new vaccine under development at Duke University has the potential to protect against a broad variety of coronavirus infections that move from animals to humans, now and in the future. Dr. Kevin Saunders, director of research, Duke Human Vaccine Institute discusses this alongside his research partner in a briefing to reporters. Watch the briefing on YouTube.

The new vaccine, called a pan-coronavirus vaccine, triggers neutralizing antibodies via a nanoparticle. The nanoparticle is composed of the coronavirus part that allows it to bind to the body’s cell receptors, and is formulated with a chemical booster called an adjuvant. Success in primates is highly relevant to humans. The findings appear Monday, May 10 in the journal Nature. Read more here.